Dr Bond on Second Cancers Following CLL Treatment
>> YOUR LINK HERE: ___ http://youtube.com/watch?v=YKB2a9OAzRA
David A. Bond, MD, assistant professor, The Ohio State University, discusses the high rates of second cancers in both treatment-naïve and pretreated patients with chronic lymphocytic leukemia (CLL) who received BTK inhibitors. • Website: https://www.onclive.com • Twitter: / onclive • Facebook: / onclive • LinkedIn: / onclive
#############################